investor review · in the u.s. (1) u.s. hospitals 1100+ (1) 15 large global market opportunity (1 )...

25
November 2017 Investor Review

Upload: others

Post on 22-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

November 2017

Investor Review

Page 2: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

This presentation contains forward-looking statements reflecting our current expectations that involve risks and uncertainties which are subject to safe harbors under the Securities Act of 1933, as amended, or the Securities Act, and the Securities Exchange Act of 1934, as amended, or the Exchange Act.

These forward-looking statements may include, but are not limited to, statements concerning our plans, objectives, expectations and intentions, future financial position, future revenues, projected costs, expectations regarding demand and acceptance for ourtechnologies, growth opportunities and trends in the market in which we operate, prospects and plans and objectives of management. The words “anticipates,” “believes,” “estimates," “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements.

These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in Part II, Item 1A, “Risk Factors” in our Quarterly Reports on Form 10-Q and in our other filings with the Securities and Exchange Commission. We do not assume any obligation to update any forward-looking statements.

2

Forward-Looking Statements

Page 3: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

VOCERAWe simplify and improve the lives of healthcare professionals, patients, and families

A recognized leader in clinical communication and workflow

solutions

Founded in 2000 HQ: San Jose, CA~600 employees40+ clinician staff

1,100 US Hospitals1,400 Customers

95%+ Maintenance Renewals

Proven ROI

Revenue GrowthOperating Leverage

Strong balance sheet (NYSE: VCRA)

62 VA Hospitals38 DoD Hospitals

JITC, DIACAP,FIPS certified

©2017 Vocera Communications. All rights reserved.

3

Page 4: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

4

• Large market shifting toward Vocera

• Market leader with compelling ROI

• Large wins validate sales strategy

• Software acquisition extends platform

• Accelerating operating leverage

Our Opportunity

*Earnings before interest, taxes, depreciation and amortization, and further excludes stock -based compensation and change in fair value of warrant and option liabilities. See appendix for a reconciliation.

**Represents the high end of the company’s guidance range

$95$104

$128

$162

-13%

-3%

3%

6%

-15%

-10%

-5%

0%

5%

10%

0

20

40

60

80

100

120

140

160

180

FY14 FY15 FY16 FY17 Guide - High

Revenue $M A-EBITDA %

Page 5: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

Drivers - Clinical Communication Challenges

(1) Joint Commission Center for Transforming Healthcare Releases Targeted Solutions Tool for Hand-Off Communications 2012. (2) Ponemon Institute, as cited in WSJ, May 2013. (3) CRICO Strategies. Malpractice risk in communication failures; 2015 Annual Benchmarking Report, as cited by The Joint Commission in 2017 Sentinel Alert. (4) Association for the Advancement of Medical Instrumentation: Alarms Pose Challenges to Healthcare Facilities, Horizons, Spring 2011, cited in The Joint Commission Sentinel Alert Medical device alarm safety in hospitals April 2013 (6) Healthcare IT News December 2015 (7) Brixey, A. Interruptions in Workflow for RNs in a Level One Trauma Center. IJMI. April 2008. (8) WSJ July 2014.

Communication failures contributed to 30% of malpractice claims resulting in 1,744 deaths over 5 years3

Tens of thousands of alarm signals occur throughout a hospital per day and 85-99% don’t require clinical intervention4

Nurses are interrupted more than 12 times per hour7, and may spend less than two hours of a 12-hour shift in direct patient care8

Miscommunication is behind 80% of serious medical error in hospitals1

Cybercriminalsare increasingly going after targets in the medical and healthcare verticals6

$8.3 billion wasted annually

In U.S. hospitals as a result of communication inefficiencies2

5

Page 6: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

Vocera Before Vocera Now

Communications

Badge-Centric

Point Product

Department Sale

Clinical Workflow

Software-Centric

Complete Solution

Enterprise Sale

Strategic Evolution

6

Page 7: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

7

10 minute savingsper nurse per shift

Bed turnover rates up 50%

OR revenues up $780,000

350 more annual OR capacity hours

4,000 annual ED hours recaptured

Operational Efficiency

Response times down from 2 minutes to9 seconds

35% overall satisfaction rating improvement

25% improvement in HCAHPS scores

Fall related injuries down 60%; estimated $1.27 mm savings

Patient Safety and Satisfaction

Compelling Return on Investment

Page 8: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

8

MEDCOM

Recent Platform Wins Validate Strategy

Page 9: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

Quality ResiliencyPatient-CenteredCostEnhance how care is

provided to help patients to achieve

better outcomes

Increase operational efficiencies

Improve patient experience by allowing

caregivers to be Patient Centered

Improve the caregiver experience by improving

workflow and empowering care teams

The Quadruple Aim

9

Our Mission

Page 10: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

10

Vocera Platform Improves the Patient Journey

Clinical Communication

Smartphones and Wearable Devices

Care Experience

Staff Assignment

Alarm and Alert Management

System Integration and Interoperability

Admission, discharge,

transfer

Test results

Nurse-physician consult

Obtain, clarify, change

orders

Update Patient status

Streamline Patient

flow

Page 11: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved.

11

Broadcast to OR Turnover

Call on-call Orthopedic Surgeon

Secure text to on-call Cardiologist

Urgent call to ED Charge Nurse

The Call Sheet Transformed

Page 12: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

12

Communicate, Collaborate, Make Informed Decisions Quickly

PHYSICIAN Collaborate whether inside

or outside the hospital

NURSEReach the right person

without names or numbers

NURSE SUPERVISOR Keep nurses and

patients safer

HOSPITALIST Receive timely, relevant

patient information

HOUSEKEEPING Increase bed turnover

Alert & Alarm Intelligence

Electronic Health Record

Nurse Call

Physiologic Monitor

Bed Management

Real-TimeLocation System

Laboratory Info System

INPUTSDynamic Data

Aggregation of PatientEvents and Context

OUTPUTSContext-Aware EventsResponse and Critical

Collaboration

Dynamic Master Directory

Page 13: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

Device of Choice Differentiator

Hands-Free BYOD or in House Tablet Desktop/ WOW

13

Page 14: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

14

Competitive Landscape

Complete end-to-end solution

Device of choice

Hands-free

Role-based intelligence

= we win > 75% of the time

Enterprise Class

Clinical integration

Secure

World class service/support

Stat

us

Qu

oW

ire

less

D

evic

es

Smar

tph

on

e A

pp

s

Page 15: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

6,986 Hospitals in the U.S.(1)

U.S. Hospitals1100+

(1)

15

Large Global Market Opportunity

(1 ) Based on Definitive US Healthcare Database. As of January 1, 2017(2) Definitive Healthcare database

International Healthcare Facilities

230+

Global Non-Healthcare Facilities

270+

Fed Hospitals(1)

Vocera Total(2)

VA 62 168

DoD 38 48

Total 100 216

~$6 Billion Global Market Opportunity

11085200

Vocera Hospitals US Hospitals

18% U.S. Penetration Rate(2)

(6308 Total US Hospitals)

Page 16: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

• Large system deals

• Further penetrate existing health system customers

• Continue pace of new customer acquisition

Building momentum across new products

• EHR Integration

• Collaboration Suite

• Clinical Integration

• Event Driven Alerts

• Care Experience

Extend reach to new users

• Physicians

• Long Term Care

• Surgery Centers

Attractive international markets

• Canada

• United Kingdom

• Saudi Arabia

• UAE

• Qatar

• Australia

• New Zealand

Core Customer Growth

Software

New Users

International Expansion

16

Our Opportunity: Multiple Avenues for Growth

Page 17: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

17

% of 2016 Revenue

16%

Maintenance*All recurring

34%

Services*15%+ recurring

11%

39%Devices *50% recurring

Diversified Revenue, High Visibility

• 60% revenues are recurring

• High visibility

• Low customer concentration

Software*15%+ subscription

Page 18: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

(1) Earnings before interest, taxes, depreciation and amortization, and further excludes stock -based compensation and change in fair value of warrant and option liabilities.

See appendix for a reconciliation.

Revenue Highlights

Adjusted EBITDA

$33.8 $42.3 $91.7

$117.0

Q316 Q317 YTD '16 YTD '17

($ in

Mill

ion

s)

-$2.8

$4.3 $3.8

2015 2016 2017YTD

($ in

Mill

ion

s)

Strong Revenue Growth• Q3’17: 25% Revenue Growth

• Product: +20%, Services: +32%

• YTD’17: 27% Revenue Growth

Solid Customer Base and Value Proposition• 95%+ s/w maintenance renewal rate

• Strong competitive win rate

Expanding Profitability and Cash Flow• 2017 A-EBITDA guidance: $7.0 -10.5 million

• $67.5 million of Cash, no Debt

18

+25% +27%

Financial Highlights

Page 19: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

19

Q4’17 Revenue Visibility

Rev from Def. Rev/BL Supplies Visible Revenue Book-ship Q4'17 Revenue

$45M*

(*high end of guidance)

Page 20: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

20

Actual

2014 2015 2016

R&D % of Revenue 17% 15% 13%

S&M % of Revenue 47% 41% 37%

G&A % of Revenue 13% 12% 11%

Target Model

12%

29%

8%

Sales

Notes

• All numbers are non-GAAP, see appendix for reconciliation. • Mean peer group enterprise value comps are 3-4x Revenue and 12-15x A-EBITDA

Drivers

Operating Leverage Drives Significant Value

Page 21: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

Appendix

Page 22: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

22

GAAP to Non-GAAP Reconciliation YTD 2017Vocera Communications, Inc.

Nine months ended September 30, 2017

Stock Intangible Acquisition

(In thousands) GAAP compensation amortization related Total Non-GAAP

2017 expense (a) (b) expense (c) adjustments 2017

Reconciliation of GAAP Gross Profit to Non-GAAP Gross Profit (Unaudited)

Revenue

Product $ 63,940 — — — $ — $ 63,940

Service 53,105 — — — — 53,105

Total revenue 117,045 — — — — 117,045

Cost of revenue

Product 20,424 309 2,222 — 2,531 17,893

Service 28,358 1,808 — 229 2,037 26,321

Total cost of revenue 48,782

2,117

2,222

229

4,568

44,214

Gross profit $ 68,263 $ 2,117 $ 2,222 $ 229 $ 4,568 $ 72,831

Stock Intangible Acquisition

(In thousands) GAAP compensation amortization related Total Non-GAAP

2017 expense (a) (b) expense (c) adjustments 2017

Reconciliation of GAAP Operating Expenses to Non-GAAP Operating Expenses (Unaudited)

Research and development $ 20,944

$ 1,542

$ —

$ 47

$ 1,589

$ 19,355

Sales and marketing 45,789

4,697

1,154

15

5,866

39,923

General and administrative 17,767

4,848

166

718

5,732

12,035

Total operating expenses $ 84,500

$ 11,087

$ 1,320

$ 780

$ 13,187

$ 71,313

Page 23: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

23

GAAP to Non-GAAP Reconciliation 2016Vocera Communications, Inc.

Year ended December 31, 2016 Stock Intangible Acquisition (In thousands) GAAP compensation amortization related Total Non-GAAP 2016 expense (a) (b) expense (c) adjustments 2016 Reconciliation of GAAP Gross Profit to Non-GAAP Gross Profit (Unaudited) Revenue

Product $ 70,667 $ — $ 70,667

Service 57,029 — 57,029

Total revenue 127,696 — — — — 127,696 Cost of revenue

Product 22,788 235 672 907 21,881

Service 26,287 1,153 — 274 1,427 24,860

Total cost of revenue 49,075 1,388 672 274 2,334 46,741

Gross profit $ 78,621 $ (1,388 ) $ (672 ) $ (274 ) $ (2,334 ) $ 80,955 Stock Intangible Acquisition (In thousands) GAAP compensation amortization related Total Non-GAAP 2016 expense (a) (b) expense (c) adjustments 2016 Reconciliation of GAAP Operating Expenses to Non-GAAP Operating Expenses (Unaudited)

Research and development $ 18,266 $ 1,158 $ — $ 23 $ 1,181 $ 17,085

Sales and marketing 52,811 4,625 415 399 5,439 47,372 General and administrative 24,499 4,864 288 5,126 10,278 14,221 Total operating expenses $ 95,576 $ 10,647 $ 703 $ 5,548 $ 16,898 $ 78,678

(a) This adjustment reflects the accounting impact of non-cash stock-based compensation expense. (b) This adjustment reflects the accounting impact of acquisitions in 2010, 2014 and 2016 in non-cash expense.

(c) This adjustment reflects the costs associated with the acquisition in 2016.

Page 24: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

24

GAAP to Non-GAAP Reconciliation 2015

Year ended December 31, 2015 Stock Intangible (In thousands) GAAP compensation amortization Litigation Total Non-GAAP 2015 expense (a) (b) expense (c) adjustments 2015 Reconciliation of GAAP Gross Profit to Non-GAAP Gross Profit (Unaudited) Revenue

Product $ 55,716 $ — $ 55,716

Service 48,370 — 48,370

Total revenue 104,086 — — — — 104,086 Cost of revenue

Product 19,666 232 323 555 19,111

Service 19,844 1,036 — 1,036 18,808 Total cost of

revenue 39,510 1,268 323 — 1,591 37,919

Gross profit 64,576 (1,268 ) (323 ) — (1,591 ) 66,167 Reconciliation of GAAP Operating Expenses to Non-GAAP Operating Expenses (Unaudited)

Research and

development 16,990 1,072 — 1,072 15,918

Sales and marketing 47,647 4,486 229 4,715 42,932 General and

administrative 16,734 4,179 243 9 4,431 12,303 Total operating

expenses 81,371 9,737 472 9 10,218 71,153

(a) This adjustment reflects the accounting impact of non-cash stock-based compensation expense. (b) This adjustment reflects the accounting impact of acquisitions in 2010 and 2014 in non-cash expense.

(c) This operating expense adjustment reflects class action litigation expenses from the August 2013 lawsuit.

Page 25: Investor Review · in the U.S. (1) U.S. Hospitals 1100+ (1) 15 Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive

©2017 Vocera Communications. All rights reserved. ©2017 Vocera Communications. All rights reserved.

25

GAAP to Non-GAAP Reconciliation 2014

Vocera Communications, Inc.

Year ended December 31, 2014Stock Intangible Acquisition

(In thousands) GAAP compensation amortization related Litigation Restructuring Total Non-GAAP

2014 expense (a) (b) expense (c) expense (d) expense (e) adjustments 2014

Reconciliation of GAAP Gross Profit to Non-GAAP Gross Profit (Unaudited)

Revenue

Product $ 51,095 - - - - - $ - $ 51,095

Service 44,326 - - - - - - 44,326

Total revenue 95,421 - - - - - - 95,421

Cost of revenue

Product 18,766 254 429 - - 72 755 18,011

Service 18,470 924 - - - 26 950 17,520

Total cost of revenue 37,236 1,178 429 - - 98 1,705 35,531

Gross profit $ 58,185 $ (1,178) $ (429) $ - $ - $ (98) $ (1,705) $ 59,890

Stock Intangible Acquisition

(In thousands) GAAP compensation amortization related Litigation Restructuring Total Non-GAAP

2014 expense (a) (b) expense (c) expense (d) expense (e) adjustments 2014

Reconciliation of GAAP Operating Expenses to Non-GAAP Operating Expenses (Unaudited)

Research and development $ 18,035 $ 1,056 - $ 11 - - $ 1,067 $ 16,968

Sales and marketing 49,611 4,111 291 - - - 4,402 45,209

General and administrative 18,062 4,739 93 888 630 - 6,350 11,712

Restructuring 556 - - - - 556 556 -

Total operating expenses $ 86,264 $ 9,906 $ 384 $ 899 $ 630 $ 556 $ 12,375 $ 73,889

(a) This adjustment reflects the accounting impacts of non-cash stock-based compensation expense.

(b) This adjustment reflects the accounting impact of acquisitions in 2010 and 2014 in non-cash expense.

(c) This operating expense adjustment reflects the accounting impact of acquisitions, including for Q4 2014 $800K of consideration

deemed to be compensation.

(d) The operating expense adjustment reflects class action litigation expenses from the August 2013 lawsuit.

(e) This operating expense adjustment reflects the impact of restructuring expense.